Related Experiment Video
Updated: Jun 2, 2026
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
Mouse models of myeloproliferative neoplasms: JAK of all grades
Juan Li1, David G Kent, Edwin Chen
1Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
Abstract:
In 2005, several groups identified a single gain-of-function point mutation in the JAK2 kinase that was present in the majority of patients with myeloproliferative neoplasms (MPNs). Since this discovery, much effort has been dedicated to understanding the molecular consequences of the JAK2V617F mutation in the haematopoietic system. Three waves of mouse models have been produced recently (bone marrow transplantation, transgenic and targeted knock-in), which have facilitated the understanding of the molecular pathogenesis of JAK2V617F-positive MPNs, providing potential platforms for designing and validating novel therapies in humans. This Commentary briefly summarises the first two types of mouse models and then focuses on the more recently generated knock-in models.
Insights
Researchers identified the JAK2V617F mutation in myeloproliferative neoplasms (MPNs). Mouse models, particularly knock-in models, are crucial for understanding MPN pathogenesis and developing new therapies.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- A JAK2 kinase gain-of-function point mutation (JAK2V617F) is prevalent in myeloproliferative neoplasms (MPNs).
- Understanding the molecular impact of JAK2V617F in the hematopoietic system is critical for MPN research.
Purpose of the Study:
- To summarize the utility of different mouse models in studying JAK2V617F-positive MPNs.
- To highlight the significance of recently developed knock-in models for understanding MPN pathogenesis.
Main Methods:
- Review of bone marrow transplantation and transgenic mouse models for JAK2V617F-positive MPNs.
- Focus on the application and insights gained from targeted knock-in mouse models.
Main Results:
- JAK2V617F mutation is a key driver in the majority of MPN patients.
- Multiple generations of mouse models have advanced the understanding of MPN molecular pathogenesis.
- Knock-in models offer a refined platform for studying JAK2V617F effects.
Conclusions:
- Mouse models are instrumental in elucidating the molecular basis of JAK2V617F-driven MPNs.
- Targeted knock-in models represent a significant advancement in MPN research.
- These models provide valuable preclinical platforms for therapeutic development in MPNs.
More Related Videos
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:15Differentiation of Common Myeloid Progenitor Cells